TX-PLANVIEW
21.5.2020 16:02:05 CEST | Business Wire | Press release
Planview® today announced it has ranked highest for both the Single Lean/Kanban Team and Scaled Agile Framework® (SAFe) Use Cases in the Gartner “Critical Capabilities for Enterprise Agile Planning Tools*” report. The research assessed 16 enterprise Agile planning tool offerings across six use cases. In addition to receiving the highest score in the Single Lean/Kanban Team and SAFe Use Cases, Planview received the second highest scores in the Distributed Agile and the Project and Program Portfolio Use Cases.
“The key to success in any Agile transformation is leveraging solutions that empower your teams at every stage of the journey,” said Patrick Tickle, Planview Chief Product Officer. “We’re pleased to be recognized by Gartner for the Single Lean/Kanban Team and SAFe Use Cases. We believe these two methods are at the core of today’s transformations – scaling with SAFe and the accelerating use of Kanban to support continuous delivery and business agility.”
In today’s fast-paced, highly disruptive markets, teams must leverage a variety of work methodologies and processes to get work done, such as Lean, Agile, Scrum, Kanban, Scrumban, and traditional project delivery. Planview’s full spectrum of Portfolio and Work Management solutions help enterprises transform strategy to delivery. In particular, Planview’s approach to Enterprise Kanban ensures organizations, from the Agile teams to the business, can continue to deliver value quickly and effectively, without giving up visibility and management to broader strategic outcomes.
Planview was also recently recognized as a Leader in the 2020 Gartner Magic Quadrant for Enterprise Agile Planning Tools **, which positioned the company as highest on the ability to execute axis. The 2020 Gartner Critical Capabilities for Enterprise Agile Planning Tools research complements the companion 2020 Gartner Magic Quadrant for Enterprise Agile Planning Tools, and looks at product capabilities and how those capabilities can be applied to use cases.
To learn more about the Planview Lean and Agile Delivery Solution visit: planview.com/lean-agile-delivery .
Additional Resources:
- Blog: Lean into the Changing World of Work
- Guide: The Ultimate Lean and Agile Software Solution Buyer’s Guide
- Whitepaper: 7 Benefits of Scaling Agile
- 3 Minute Pathfinder: Lean-Agile Pathfinder
- Follow the Planview Blog
- Connect with Planview on Twitter , Facebook and LinkedIn
*Gartner, Critical Capabilities for Enterprise Agile Planning Tools by Mike West, Keith Mann, Bill Blosen, Akis Sklavounakis, Deacon D.K Wan, April 29, 2020
**Gartner, Magic Quadrant for Enterprise Agile Planning Tools by Keith Mann, Mike West, Bill Blosen, Akis Sklavounakis, Deacon D.K Wan, April 21, 2020
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose
About Planview
Planview has one focus: enabling the transformation journey as organizations rewire strategy to delivery in today’s fast-paced, highly disruptive markets. Our solutions uniquely help organizations navigate this journey and accelerate on-strategy delivery at enterprise scale. Planview’s full spectrum of Portfolio Management and Work Management solutions create organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enable customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, Planview has more than 700 employees supporting 3,500 customers and 1 million users worldwide. For more information, visit https://www.planview.com/ .
Planview and the Planview logo are registered trademarks of Planview, Inc. All other trademarks are property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200521005447/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SymphonyAI Launches Eight AI Applications Purpose-Built for Energy Asset Reliability and Operational Performance20.4.2026 07:09:00 CEST | Press release
Eight AI applications engineered for asset reliability, operational performance, and emissions obligations SymphonyAI, a global leader in Vertical AI platforms, today announced eight new industrial AI applications purpose-built for energy operators, marking the most targeted expansion of IRIS Foundry into the energy sector to date. Unlike generic asset management software, these applications are engineered around the specific failure modes, process dynamics, and regulatory obligations of energy and resources operations — compressor surge, heat exchanger fouling, pipeline integrity degradation, refinery unit yield loss, and the growing compliance burden of EU methane regulation and emissions reporting. By combining SymphonyAI’s deep industrial ontology with IRIS Foundry’s ability to unify IT, OT, and IoT data from historians, SCADA systems, inspection databases, and enterprise platforms into a single governed intelligence layer, the new suite delivers causal AI at the point where energy
Petronor and H2SITE Partner to Pioneer High-Purity Hydrogen Production in Refining Through Advanced Membrane Technology20.4.2026 07:00:00 CEST | Press release
H2SITE, a technology company specialised in advanced hydrogen production and separation solutions, has signed a strategic agreement with Petronor, a leading refinery and key industrial player in the energy sector with a clear commitment to achieving net-zero emissions, to deploy its high-efficiency hydrogen separation technology at Petronor’s refinery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419792308/en/ The partnership sets the stage for the joint development of a pioneering First-of-a-Kind (FOAK) unit, integrating H2SITE’s proprietary membrane technology into the Steam Methane Reforming (SMR) process in refineries to improve overall plant efficiency, enhance CO₂ capture opportunities, and ultimately strengthen operational performance and industrial competitiveness. Petronor’s engineering and operations teams are joining forces with H2SITE’s technical experts, leveraging decades of refinery expertise, industrial
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock20.4.2026 01:07:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company’s common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling any shares of its common stock in the offering. The Selling Stockholder will receive all of the proceeds from the offering. Maxim Group LLC is acting as the sole book-running manager and Roth Capital Partners is acting as the co-manager for the offering. The offering is being made pursuant to the Com
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms20.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, will unveil a new ‘all-in-one’ powertrain at Beijing Auto Show 2026: the X-Range C15 Direct Drive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419640202/en/ Left-facing view of the HORSE X-Range C15 Direct Drive The ultra-compact X-Range C15 Direct Drive integrates a full hybrid powertrain – including a 4-cylinder engine, transmission, power electronics, and an electric motor – into a single compact unit with a shared housing, designed to mount to the rear subframe enabling a double isolated installation for best NVH. The X-Range C15 Direct Drive is designed as an ‘all-in-one’ powertrain to replace the rear electric drive unit of an existing BEV platform. It enables an automaker to use a single shared platform for their BEV, HEV, PHEV, and REEV lineups without any significant changes to vehicle design or production environments. The ne
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom